MoneyWorks4Me

Raymed Labs - Quaterly Results

06 Nov 2024 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended September 2024, as compared to corresponding quarter of last year.The Net Loss for the quarter ended September 2024 is Rs. -0.16 millions as compared to Net Loss of Rs. -0.17 millions of corresponding quarter ended September 2023 Operating profit Margin for the quarter ended September 2024 improved to -0.15% as compared to -0.16% of corresponding quarter ended September 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.21 0.00
PBIDT -0.15 -0.16 -6.25 -0.31 -0.31 0.00 -0.97 -1.65 -41.21
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.15 -0.16 -6.25 -0.31 -0.31 0.00 -0.97 -1.65 -41.21
Depreciation 0.01 0.01 0.00 0.03 0.02 50.00 0.05 0.06 -16.67
PBT -0.16 -0.17 -5.88 -0.34 -0.33 3.03 -1.02 -1.71 -40.35
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.16 -0.17 -5.88 -0.34 -0.33 3.03 -1.02 -1.71 -40.35
Equity 42.74 42.74 0.00 42.74 42.74 0.00 42.74 42.74 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Peers
Company Name CMP
Uflex 663.05
EPL 238.55
AGI Greenpac 803.90
Huhtamaki India 242.40
TCPL Packaging 4107.35
View more..